Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESAGE: Fertility Preservation by Ovarian Stimulation With Tamoxifen Prior to Chemotherapy for Breast Cancer
NCT02890082Phase 2Active, not recruiting
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Feb 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tamoxifen in breast cancer (3 arms), sponsored by Institut Cancérologique de l'Ouest. Primary endpoint: Feasibility of ovarian stimulation at 1 month. Started Feb 2014; status: active, not recruiting.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02890082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02890082.